stella
beta
Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC — Stella
Recruiting
Back to Recurrent or Metastatic Nasopharyngeal Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong
View full record on ClinicalTrials.gov